内镜微创联合膀胱内灌注在女性腺性膀胱炎中的应用价值分析

Value analysis of minimally invasive endoscopic resection combined with intravesical women glandular cystitis

目的对内镜微创联合膀胱内灌注治疗女性腺性膀胱炎中的应用价值进行探讨。方法选取80例腺性膀胱炎女性患者作为研究对象。按照随机对照原则分为研究组和对照组。研究组给予经尿道等离子电切术联合术后吡柔比星膀胱灌注治疗,对照组给予经尿道电灼术联合术后吡柔比星膀胱灌注治疗。对两组采取不同手术方式的患者手术时间、出血情况及临床疗效进行比较。结果 1对两组患者治疗手术时间及出血情况及住院时间进行比较发现,差异无显著性(P>0.05)。2研究组治愈29例,总有效率为97.5%;对照组治愈24例,总有效率为85.0%;对治疗总有效率进行比较发现,差异具有显著性(χ2=3.91,P<0.05)。3对两组患者并发症发生情况进行比较,差异具有显著性(χ2=4.26,P<0.05)。结论经尿道等离子电切术联合术后吡柔比星膀胱灌注治疗具有手术时间缩短、出血量少、创伤小、恢复快及疗效显著等优点,在治疗腺性膀胱炎方面是一种安全、有效且微创的治疗方法。

【Objective】To explore the application value of minimally invasive endoscopic resection combined with intravesical treatment of women glandular cystitis. 【Methods】80 female patients with glandular cystitis were chosen as research subjects. They were divided into two groups according to the principles of a randomized controlled method. Study group received transurethral resection of the joint plasma after intravesical pirarubicin treatment; the control group was given after transurethral fulguration joint THP intravesical therapy. The operation time,bleeding and clinical efficacy were compared. 【Results】1Treatment and hospitalization time and bleeding time of two groups had no statistically significant difference（P〉0.05）. 229 cases of study group were cured, total effective rate was 97.5%; 24 cases cured in the control group, the total effective rate was 85.0%; total efficiency of the treatment was statistically significant difference（χ2=3.91, P〈0.05）. 3Complications between the two groups of patients were statistically significant difference（χ2=4.26, P0.05）.【Conclusion】Transurethral resection of the joint plasma pirarubicin after intravesical treatment with a shorter operative time, less bleeding, less trauma, quicker recovery, a significant effect, etc. It is a safe, effective and minimally invasive for the treatment of glandular cystitis.